Scientists Find Immune Cell Reservoirs in Pancreatic Lymph Nodes of People with Type 1 Diabetes

Type 1 diabetes develops when the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. But researchers have long wondered: where do the immune cells that drive this attack actually live and persist? A new study published in The Journal of Clinical Investigation offers an important clue by examining the pancreatic lymph nodes—tiny immune-filtering stations located near the pancreas—in people with established type 1 diabetes.

Scientists have known for years from mouse studies that these lymph nodes play a critical role. In fact, removing pancreatic lymph nodes in laboratory mice prevented type 1 diabetes from developing. Now, for the first time, researchers have found similar patterns in humans, identifying a population of stem-like CD8+ T cells living in the pancreatic lymph nodes of people with type 1 diabetes.

The newly identified cells are described as "stem-like" because they have a special ability: they can renew themselves over time. Unlike most immune cells that mount a brief response and then fade away, these stem-like CD8+ T cells appear capable of sustaining the autoimmune response for the long term—potentially explaining why type 1 diabetes persists as a lifelong condition once it develops.

This self-renewing quality is not unique to type 1 diabetes. Similar stem-like immune cell populations have been observed in cancer research, where long-lived immune cells help drive chronic disease. The new findings suggest that type 1 diabetes may work in a comparable way, with these special cells serving as an ongoing source of autoimmune persistence.

The research also uncovered evidence for a developmental pathway connecting immune cells in the pancreatic lymph nodes to immune activity directly in the pancreas itself. In other words, the stem-like cells in the lymph nodes appear to be linked to autoreactive immune clones found within pancreatic tissue—suggesting these two compartments work together to sustain the autoimmune attack.

However, scientists emphasize that the precise relationship between these stem-like cells and the specific pathogenic clones causing damage remains unclear. Much more research is needed to fully understand how these populations interact and drive disease progression.

By identifying pancreatic lymph nodes as a potential reservoir of autoimmune persistence, this work opens a new window for therapeutic intervention. If researchers can develop ways to target or interrupt these stem-like immune cell populations, it might be possible to reduce or stop the ongoing autoimmune attack in type 1 diabetes.

The study positions pancreatic lymph nodes as a key target for future immune-based therapies, though much work lies ahead. Scientists must first fully characterize these cells, understand their behavior, and then test whether interventions can safely and effectively alter their activity. This research represents an important step forward in that longer journey.

Source: The Journal of clinical investigation. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.